Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Keyword
- Publication
- Publication Type
- File Type
Articles 1 - 5 of 5
Full-Text Articles in Dermatology
Using Intense Pulse Light To Treat Facial Erythema Associated With Subcutaneous Lupus Erythematous: A Case Report, Melissa Jomsky, Jonathan D. Melnick, Marc Kesselman, Matthew B. Zarraga Do, Michelle L. Demory
Using Intense Pulse Light To Treat Facial Erythema Associated With Subcutaneous Lupus Erythematous: A Case Report, Melissa Jomsky, Jonathan D. Melnick, Marc Kesselman, Matthew B. Zarraga Do, Michelle L. Demory
HCA-NSU MD Research Day
Introduction: Subcutaneous Lupus Erythematous (SCLE), a cutaneous form of Lupus Erythematous (LE), is an autoimmune disease which manifests as a chronic skin condition that may or may not include systemic involvement. SCLE occurs in every 4 people per 100,000, which has remained a consistent occurrencerate over the past 40 years. Currently, first line therapy for the skin manifestations of LE are topical and systemic steroids, which pose a risk of long-term side effects. Herein, we suggest a series of Intense Pulse Light (IPL) sessions as a treatment optionfor the malar rash associated with SCLE to improve the appearance of the …
Skin Manifestations In People With Hepatitis C, Erjola Toska, Cameron Minars, Suzanne Riskin
Skin Manifestations In People With Hepatitis C, Erjola Toska, Cameron Minars, Suzanne Riskin
HCA-NSU MD Research Day
Skin Manifestations in People with Hepatitis C Authors: Erjola Toska, OMS-III, Cameron Minars, OMS-II, Suzanne Riskin, M.D. Objectives: This study is aimed to summarize the association between hepatitis C infection and dermatological manifestations from the past decade. Background: Hepatitis C is a growing global health concern, with rising incidence rates and an increased likelihood of extrahepatic manifestations, including dermatological conditions. Despite research into the connection between hepatitis C and skin disorders, there is a lack of comprehensive reviews on this subject. Methods: Four databases—PubMed (NLM), EMBASE, CINAHL, and Web of Science—were searched for peer-reviewed articles written in English, focusing on …
Nourishing Skin Health: The Impact Of A Balanced Diet On Chronic Inflammatory Skin Conditions, Archana Banda
Nourishing Skin Health: The Impact Of A Balanced Diet On Chronic Inflammatory Skin Conditions, Archana Banda
HCA-NSU MD Research Day
Objective: This study was conducted to determine the influence a balanced diet has on the outcome of specific dermatologic conditions notably psoriasis, atopic dermatitis, and rosacea. Background: Nutritional status is pivotal in shaping holistic wellness, which extends to skin health. Adequate nutrition can prevent the worsening of inflammatory conditions. Methods: A literature review was conducted to analyze how specific dietary habits for selected chronic inflammatory cutaneous conditions influence the presentation and overall clinical outcome. Results: The analysis indicates a higher incidence of flare-ups with diets heavily consisting of carbohydrates, red meat, alcohol, and fats. Specific diets, such as the Western …
Visualdx, Tariq Rahaman
Visualdx, Tariq Rahaman
Library Learn - Complete Video Collection
VisualDx is a clinical decision support tool and is available via NSU Libraries. The attached PDF contains instructions for accessing the mobile app.
For tutorials on using the VisualDx platform, visit the website.
A Comparison Of Various Monoclonal Antibodies To The Previous Standard Of Care Chemotherapy In The Treatment Of Advanced-Stage Melanoma, Kevin Verde, Lauren Johnson, Alex Clancy, Ashley Goldberg, Aleia Monden, Priya Philip
A Comparison Of Various Monoclonal Antibodies To The Previous Standard Of Care Chemotherapy In The Treatment Of Advanced-Stage Melanoma, Kevin Verde, Lauren Johnson, Alex Clancy, Ashley Goldberg, Aleia Monden, Priya Philip
Internet Journal of Allied Health Sciences and Practice
In the year 2015, it is estimated that the number of new cases of invasive melanoma will be 42,670 in males and 31,200 in females.1 Melanoma is treatable with early diagnosis; however, more advanced disease has devastating outcomes. For the past decade, two chemotherapy agents, dacarbazine and temozolomide, have been the treatment of choice for advanced stage III or IV melanoma requiring systemic treatment. Interleukin-2 (IL-2) therapy has been used but with serious side effects. More recently, the focus has shifted to monoclonal antibodies and enzyme inhibitors as the main systemic treatment for advanced cutaneous melanoma. This literature review …